Parkinson’s Disease

Gregory Stafford Excerpts

Wednesday 21st May 2025 Westminster Hall

[Gregory Stafford (Farnham and Bordon) (Con)]

It is a pleasure to serve under your chairmanship, Mr Stuart. I thank the hon. Member for Colne Valley (Paul Davies) for his role in securing this vital debate and all Members who contributed.

As we have heard today, Parkinson’s affects 153,000 people in the UK; more shockingly, every hour, two more people are diagnosed. For me, the issue is personal: a close family member was initially diagnosed and treated for Parkinson’s, but more recently that diagnosis was revised to progressive supranuclear palsy—a rarer and more aggressive condition. That journey from uncertainty to diagnosis and then to living with a progressive neurological condition has profoundly impacted me. I have witnessed first hand the critical importance of early diagnosis, emotional support, specialist care and—above all—hope.

Last month, ahead of World Parkinson’s Day, I met representatives of Parkinson’s UK and individuals affected by the condition. I heard powerful accounts from volunteers about the daily challenges that they face with mobility issues, speech difficulties and the emotional toll on themselves and their families. I will continue to commend Parkinson’s UK for its tireless work, both across my constituency of Farnham and Bordon, including Haslemere, Liphook and the surrounding villages, and across the country, providing advice, support and advocacy at every stage of the Parkinson’s journey.

However, I have been concerned that the Labour Government have yet to identify Parkinson’s as a strategic priority. Will the Minister confirm what level of funding is being allocated to Parkinson’s research this year? How does that compare with the past five years? During my tenure at the NHS Getting It Right First Time programme, I was involved in the publication of the neurology national specialty report. That analysis highlighted significant variation in neurological services across England, particularly in managing conditions such as Parkinson’s disease. The recommendations are essential for reducing disparities and improving outcomes, so will the Minister commit to addressing in detail the priorities in the report, beyond general references to cutting waiting lists?

The previous, Conservative Government invested more than £79 million into research into Parkinson’s between 2019 and 2024; in 2022-23, the National Institute for Health and Care Research enabled 114 studies related to Parkinson’s through its infrastructure. We also rolled out a new treatment for advanced Parkinson’s disease through the NHS, which started in February last year, offering an additional option for patients whose symptoms were no longer responding to oral medication. I would be grateful if the Minister could confirm that the Government plan to continue that momentum. What research funding will be maintained or increased and what new treatment options are being supported or explored? The new Government have committed to updating the last Conservative Government’s long-term workforce plan. When will they announce the detail and what specialist training there will be for Parkinson’s nurses and clinicians? Will they maintain the focus on specialist care?

Charities such as Parkinson’s UK do an amazing job, but as with many other sectors they are having to respond to higher taxes and squeezed funding. Will the Minister outline how he is talking to the charitable sector to ensure that the changes that the Government are making in the Budget are not damaging Parkinson’s care?

Finally, what guarantees can the Minister offer that the recent restructuring of NHS England will not worsen access to Parkinson’s services? With 50% cuts to integrated care boards, can the Minister reassure people that Parkinson’s sufferers and their families will not be disadvantaged?

Members from across the House are united in wanting to improve treatment, support and outcomes for people with Parkinson’s. In response to a debate I spoke in earlier this month, the Public Health Minister said that she would be happy to meet with stakeholder organisations to discuss the Parky charter and the progress of Parkinson’s Connect pilots. I would be grateful if the Minister could outline whether the Public Health Minister has arranged those meetings and, if she has not, when they might happen. A meeting would prove the Government’s action on workforce, waiting times, integration, support for carers, and access to research and innovation.

My colleagues in the Conservative party and I stand ready to work constructively with the Government, and with Members from all parties, to ensure that progress is not only protected but accelerated. Let us match awareness with action, for only with action will there be hope.